
Amniotic Membrane Market By Product (Cryopreserved Amniotic Membrane, Lyophilization Amniotic Membrane) By Application (Surgical Wound, Ophthalmology) By Crop Type (Hospitals, Ambulatory Surgical Centers, Specialized) and Region - Global Forecast to 2027
3456
March 2023
128
PDF
-
Request Covid 19 Impact
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
The Amniotic Membrane Market report offers in-depth insights, revenue details, and other vital information regarding the global amniotic membrane market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027.
The Amniotic Membrane Market report includes PEST analysis, Porter’s Five Forces analysis, and opportunity map analysis for an in-depth understanding of the market.
The Amniotic Membrane market report offers insightful and detailed information regarding the various key players operating in the global amniotic membrane market, their financials, technological innovations, key developments, apart from future strategies, SWOT analysis, acquisitions & mergers, and market footprint.
The global amniotic membrane market is segmented on the basis of product, application, end-user, and region.
Amniotic Membrane Market Overview:
The Amniotic Membrane Market was valued at $42.4 billion in 2021 & is projected to reach $84.9 billion by 2028. It is expected to grow at an 8.3% CAGR between 2021 and 2028.
The amniotic membrane is the thin tissue that creates the walls of the amniotic sac. It is the innermost layer of the placenta consisting of a thick basement membrane and an avascular stromal matrix. It can be used as a graft or as a dressing to facilitate ocular surface reconstruction and promote healing.
Amniotic Membrane Market Dynamics:
Major factors driving the growth of the global amniotic membrane market are the increasing adoption of amniotic membranes for performing various ophthalmic and other surgeries due to their durability, hypoallergenic, anti-inflammatory, and anti-scarring properties.
In addition, amniotic membrane grafts can reduce Pterygium recurrence, which is expected to help show reliance on the amniotic membrane, and thus increase its adoption for surgeries.
Increasing usage of amniotic membrane in injections and medicines for treating musculoskeletal diseases or disorders is expected to further increase demand and revenue growth of the market.
Increasing therapeutic treatments such as Platelet Rich Plasma Therapy (PRP), especially to treat sports injuries and athletes for a faster healing process.
PRP therapy can be used to treat injured tendons, ligaments, or joints, and could help heal the patient quicker.
It is commonly used to treat osteoarthritis of the knee, shoulder, hip, and spine, rotator cuff tears, ACL injuries, back and neck injuries, tennis elbow, tendonitis, ligament sprains, and various others.
These are among the major factors expected to drive demand for amniotic-derived products over the forecast period.
However, the growing demand for open surgeries is expected to decrease rapidly owing to the rising preference for minimally invasive surgeries that are possible using lasers and robotic technology and in turn expected to restrain revenue growth of the global amniotic membrane market over the forecast period.
Analysis by Product:
On the basis of product segmentation, the cryopreserved amniotic membrane segment is expected to contribute a major revenue share to the global market and is expected to maintain its dominance over the forecast period. The fungicide segment witnesses a CAGR over 9.0%. Cryopreserved amniotic membranes help to treat various corneal, epithelial, and conjunctival disorders, including neurotrophic ulcers, persistent epithelial defects, microbial keratitis, band keratopathy, and chemical burns. It is also used to speed up wound healing and promote regeneration of stem cells in unhealthy corneas, as well as to prevent scarring after a variety of procedures, which are major factors expected to support growth of the cryopreserved amniotic membrane segment in the global amniotic membrane market in the near future.
Analysis by Application:
Among all the application segments, the surgical wound segment accounts for the highest share in terms of revenue in the global market.
The liquid segment is projected to register a CAGR of over 8% during the forecast period.
Manufacturers are focusing on getting FDA approvals as amniotic membranes used to treat human surgical wounds need to be FDA approved, which is another factor expected to support the growth of this segment over the forecast period.
Analysis by End User:
Among all the end-user segments, the hospital's segment accounted for the highest revenue share terms of revenue in 2017 in the global market.
The segment growth is attributed to the increasing number of amniotic membrane transplants and to raising awareness about the benefits and advantages of amniotic membrane transplants in the patient pool.
Ambulatory Surgery Centers (ASCs) are also called same-day surgery centers, outpatient surgery centers, or surgicenters, and are health care facilities where surgeries are performed efficiently and do not require a hospital stay, as well as are also comparatively less complicated.
The ambulatory surgical center's segment is expected to witness a higher revenue growth rate over the forecast period attributable to various advantages such as faster recovery post-treatment, less time as hospital stay, etc.
Analysis by Region:
The growth of the amniotic membrane market in North America is attributed to the rising demand for amniotic membranes from end-users such as hospitals, ambulatory surgical centers, and specialty clinics.
The amniotic membrane is used as a graft or as a dressing in different surgical subspecialties; whereas, in ophthalmology, the amniotic membrane is used as a tissue bandage for cornea infections and sterile malts.
The Europe market accounted for a major share in terms of revenue in the global amniotic membrane market in 2017.
The market in Europe is expected to witness considerable growth in terms of revenue during the forecast period. Increasing demand for amniotic membranes for ophthalmology to treat various types of ocular disorders in countries in the region is a major factor expected to propel the growth of the market in the region over the forecast period.
Furthermore, the presence of prominent international players in the market such as Applied Biological Laboratories Inc., Tissuetech Inc., Amniox Medical, Inc., and others in the region are other factors expected to fuel the growth of the Europe amniotic membrane market.
The Asia Pacific market accounts for a significant share in terms of revenue in the global market. The Asia Pacific amniotic membrane market is expected to witness the highest growth in terms of revenue and is expected to register a CAGR of over 9% during the forecast period.
Increasing adoption of amniotic membrane in applications such as surgical wound healing and ophthalmology in countries in the region due to specific properties such as anti-scarring and anti-adhesive activity, non-immunogenic and low antigenicity, anti-microbial and analgesic effects, and anti-inflammatory effects are factors expected to drive the growth of the target market over the forecast period.
The market in Latin America accounts for over 6% of revenue share in the global market in 2017.
Increasing awareness about the benefits and advantages of advanced treatment therapies using amniotic membranes in countries in the region is a major factor expected to bolster the growth of the Latin American market to a significant extent.
Increasing government initiatives and investments in the development of medical infrastructure are also expected to propel the growth of the market to a significant extent in the near future.
Global Amniotic Membrane Market segmentation:
Segmentation on the basis of product:
- Cryopreserved Amniotic Membrane
- Lyophilization Amniotic Membrane
Segmentation on the basis of application:
- Surgical Wound
- Ophthalmology
- Others (diagnostic applications, reconstructive urology, etc.)
Segmentation on the basis of crop type:
- Hospitals
- Ambulatory Surgical Centers
- Specialized Clinics
- Research Centers and Laboratory
Segmentation on the basis of region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Tissuetech, Inc.
- Integra LifeSciences Holdings Corporation (Derma Sciences Inc.)
- Alliqua BioMedical, Inc. (Celularity, Inc.)
- Skye Biologics, Inc.
- Human Regenerative Technologies, LLC
- MiMedx Group, Inc.
- Amnio Technology, LLC
- Katena Products Inc.
- 1.0 Chapter 1
- 1.1 Preface
- 1.2 Assumptions
- 1.3 Abbreviations
- 2.1 Report Description
- 2.1.1 Market Definition and Scope
- 2.2 Executive Summary
- 2.2.1 Market Snapshot, By Product
- 2.2.2 Market Snapshot, By Application
- 2.2.3 Market Snapshot, By End User
- 2.2.4 Market Snapshot, By Region
- 2.2.5 Prudour Opportunity Map Analysis
- 3.0.1 Global Amniotic Membrane Market Dynamics
- 3.0.2 Drivers (D)
- 3.0.3 Restraints (R)
- 3.0.4 Opportunities
- 3.0.5 Trends
- 3.0.6 DR Impact Analysis
- 3.0.7 PEST Analysis
- 3.0.8 PORTER’S Five Forces Analysis
- 3.0.9 Recent Advancements
- 3.0.10 Current Trends/Issues/Challenges
- 3.0.11 Global Estimated Wound Prevalence, Wound Type
- 4.0.1 Global Amniotic Membrane Market Analysis, by Product
- 4.0.2 Overview
- 4.0.3 Segment Trends
- 4.0.4 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017–2027
- 4.1 Cryopreserved Amniotic Membrane
- 4.1.1 Overview
- 4.1.2 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017–2027
- 4.2 Lyophilization Amniotic Membrane
- 4.2.1 Overview
- 4.2.2 Market Share and Forecast, and Y-o-Y Growth, 2017–2027, (US$ Bn)
- 5.0.1 Global Amniotic Membrane Market Analysis, by Application
- 5.0.2 Overview
- 5.0.3 Segment Trends
- 5.0.4 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017–2027
- 5.1 Surgical Wound
- 5.1.1 Overview
- 5.1.2 Market Share and Forecast, and Y-o-Y Growth, 2017–2027, (US$ Bn)
- 5.2 Ophthalmology
- 5.2.1 Overview
- 5.2.2 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017–2027
- 5.3 Others
- 5.3.1 Overview
- 5.3.2 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017–2027
- 6.0.1 Global Amniotic Membrane Market Analysis, by End User
- 6.0.2 Overview
- 6.0.3 Segment Trends
- 6.0.4 Market Value (US$ Mn) and Forecast, 2017–2027
- 6.1 Hospitals
- 6.1.1 Overview
- 6.1.2 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017–2027
- 6.2 Ambulatory Surgical Centers
- 6.2.1 Overview
- 6.2.2 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017–2027
- 6.3 Specialized Clinics
- 6.3.1 Overview
- 6.3.2 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017–2027
- 6.4 Research Centers and Laboratory
- 6.4.1 Overview
- 6.4.2 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017–2027
- 7.0.1 Global Amniotic Membrane Market Analysis, by Region
- 7.0.2 Overview
- 7.0.3 Regional Trends
- 7.0.4 Market Attractiveness Index
- 7.0.5 Market Value (US$ Mn) and Forecast, 2017–2027
- 7.0.6 Elderly Population Overview, by Leading Countries
- 7.1 Global Amniotic Membrane Market Analysis, by North America
- 7.1.1 Overview
- 7.1.2 Country Trends
- 7.1.3 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017–2027
- 7.1.4 US
- 7.1.4.1 Market Value (US$ Bn) and Forecast, 2017–2027
- 7.1.5 Canada
- 7.1.5.1 Market Value (US$ Bn) and Forecast, 2017–2027
- 7.2 Global Amniotic Membrane Market Analysis, by Europe
- 7.2.1 Overview
- 7.2.2 Country Trends
- 7.2.3 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017–2027
- 7.2.4 Germany
- 7.2.4.1 Market Value (US$ Bn) and Forecast, 2017–2027
- 7.2.5 UK
- 7.2.5.1 Market Value (US$ Bn) and Forecast, 2017–2027
- 7.2.6 France
- 7.2.6.1 Market Value (US$ Bn) and Forecast, 2017–2027
- 7.2.7 Russia
- 7.2.7.1 Market Value (US$ Bn) and Forecast, 2017–2027
- 7.2.8 Italy
- 7.2.8.1 Market Value (US$ Bn) and Forecast, 2017–2027
- 7.2.9 Rest of Europe
- 7.2.9.1 Market Value (US$ Bn) and Forecast, 2017–2027
- 7.3 Global Amniotic Membrane Market Analysis, by Asia Pacific
- 7.3.1 Overview
- 7.3.2 Country Trends
- 7.3.3 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017–2027
- 7.3.4 China
- 7.3.4.1 Market Value (US$ Bn) and Forecast, 2017–2027
- 7.3.5 India
- 7.3.5.1 Market Value (US$ Bn) and Forecast, 2017–2027
- 7.3.6 Japan
- 7.3.6.1 Market Value (US$ Bn) and Forecast, 2017–2027
- 7.3.7 Australia
- 7.3.7.1 Market Value (US$ Bn) and Forecast, 2017–2027
- 7.3.8 Rest of Asia Pacific
- 7.3.8.1 Market Value (US$ Bn) and Forecast, 2017–2027
- 7.4 Global Amniotic Membrane Market Analysis, by Latin America
- 7.4.1 Overview
- 7.4.2 Country Trends
- 7.4.3 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017–2027
- 7.4.4 Brazil
- 7.4.4.1 Market Value (US$ Bn) and Forecast, 2017–2027
- 7.4.5 Mexico
- 7.4.5.1 Market Value (US$ Bn) and Forecast, 2017–2027
- 7.4.6 Rest of Latin America
- 7.4.6.1 Market Value (US$ Bn) and Forecast, 2017–2027
- 7.5 Global Amniotic Membrane Market Analysis, by Middle East & Africa
- 7.5.1 Overview
- 7.5.2 Country Trends
- 7.5.3 Market Value (US$ Mn) and Forecast, and Y-o-Y Growth, 2017–2027
- 7.5.4 GCC
- 7.5.4.1 Market Value (US$ Bn) and Forecast, 2017–2027
- 7.5.5 Israel
- 7.5.5.1 Market Value (US$ Bn) and Forecast, 2017–2027
- 7.5.6 South Africa
- 7.5.6.1 Market Value (US$ Bn) and Forecast, 2017–2027
- 7.5.7 Rest of Middle East & Africa
- 7.5.7.1 Market Value (US$ Bn) and Forecast, 2017–2027
- 8.0.1 Company Profiles
- 8.1 Tissuetech, Inc.
- 8.1.1 Company Overview
- 8.1.2 Product Portfolio
- 8.1.3 Financial Overview
- 8.1.4 Recent Developments
- 8.1.5 SWOT Analysis
- 8.1.6 Contact Information
- 8.2 Integra LifeSciences Holdings Corporation (Derma Sciences Inc.)
- 8.2.1 Company Overview
- 8.2.2 Product Portfolio
- 8.2.3 Financial Overview
- 8.2.4 Recent Developments
- 8.2.5 SWOT Analysis
- 8.2.6 Contact Information
- 8.3 Alliqua BioMedical, Inc. (Celularity, Inc.)
- 8.3.1 Company Overview
- 8.3.2 Product Portfolio
- 8.3.3 Financial Overview
- 8.3.4 Recent Developments
- 8.3.5 SWOT Analysis
- 8.3.6 Contact Information
- 8.4 Skye Biologics, Inc.
- 8.4.1 Company Overview
- 8.4.2 Product Portfolio
- 8.4.3 Financial Overview
- 8.4.4 Recent Developments
- 8.4.5 SWOT Analysis
- 8.4.6 Contact Information
- 8.5 Human Regenerative Technologies, LLC
- 8.5.1 Company Overview
- 8.5.2 Product Portfolio
- 8.5.3 Financial Overview
- 8.5.4 Recent Developments
- 8.5.5 SWOT Analysis
- 8.5.6 Contact Information
- 8.6 MiMedx Group, Inc.
- 8.6.1 Company Overview
- 8.6.2 Product Portfolio
- 8.6.3 Financial Overview
- 8.6.4 Recent Developments
- 8.6.5 SWOT Analysis
- 8.6.6 Contact Information
- 8.7 Amnio Technology, LLC
- 8.7.1 Company Overview
- 8.7.2 Product Portfolio
- 8.7.3 Financial Overview
- 8.7.4 Recent Developments
- 8.7.5 SWOT Analysis
- 8.7.6 Contact Information
- 8.8 Katena Products Inc.
- 8.8.1 Company Overview
- 8.8.2 Product Portfolio
- 8.8.3 Financial Overview
- 8.8.4 Recent Developments
- 8.8.5 SWOT Analysis
- 8.8.6 Contact Information
- 9.0.1 Research Methodology
- 9.0.2 About Us
OUR CLIENTS
Don't just take our word. We are trusted by these great companies!